Cite
MLA Citation
Heinz Gisslinger et al.. “A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial.” British journal of haematology, vol. 185, 2019, pp. 691–700. http://access.bl.uk/ark:/81055/vdc_100081483270.0x000061